Salas-Salvadó Jordi, Guasch-Ferré Marta, Lee Chih-Hao, Estruch Ramón, Clish Clary B, Ros Emilio
Human Nutrition Unit, University Hospital of Sant Joan de Reus, Department of Biochemistry and Biotechnology, Faculty of Medicine and Health Sciences, Pere Virgili Health Research Center, Rovira i Virgili University, Reus, Spain.
Biomedical Research Centre in Physiopathology of Obesity and Nutrition, Carlos III Health Institute, Madrid, Spain.
J Nutr. 2015 Apr 1;146(4):920S-927S. doi: 10.3945/jn.115.218487.
Several studies provide evidence supporting a beneficial effect from the traditional Mediterranean diet (MedDiet) on the risk of type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS). This review summarizes the current scientific evidence from epidemiologic studies and clinical trials on the relation between the MedDiet and T2DM and MetS and the possible mechanisms underlying the reported associations. A recent meta-analysis of prospective cohort studies showed that greater adherence to the MedDiet was associated with a significant reduction in the risk of diabetes. The MedDiet has also been found to be beneficial in the prevention of gestational diabetes. Four large prospective studies have observed inverse associations between the MedDiet and MetS or its components. Few randomized controlled trials (RCTs) have evaluated the effect of the MedDiet on T2DM and MetS. Results from the landmark PREvención con DIeta MEDiterránea (PREDIMED) nutrition intervention trial showed that participants assigned to the MedDiet had a significant 30% reduction in the risk of T2DM and that it also promoted the reversion of MetS and its components, hyperglycemia and central obesity. In addition, 5 RCTs showed the beneficial effects of the MedDiet compared with other dietary patterns on glycemic control in patients with T2DM. A recent meta-analysis of RCTs revealed that, compared with a variety of control diets, the MedDiet was associated with beneficial effects on all MetS components. Bioactive components of the MedDiet synergize to affect various metabolic pathways, leading to a reduced cardiometabolic disease risk. The abundance of healthy, nutrient-dense foods that make up the plant-based MedDiet predicts its bioactivity and potential to beneficially influence metabolic pathways that lead to MetS and T2DM, as well as other chronic conditions. Abundant epidemiologic and clinical trial evidence supports the role of the MedDiet on the prevention and management of T2DM and MetS.
多项研究提供了证据,支持传统地中海饮食(MedDiet)对2型糖尿病(T2DM)和代谢综合征(MetS)风险具有有益影响。本综述总结了流行病学研究和临床试验中关于MedDiet与T2DM和MetS之间关系的当前科学证据,以及所报道关联背后的可能机制。最近一项对前瞻性队列研究的荟萃分析表明,更高程度地坚持MedDiet与糖尿病风险显著降低相关。MedDiet还被发现对预防妊娠期糖尿病有益。四项大型前瞻性研究观察到MedDiet与MetS或其组成部分之间存在负相关。很少有随机对照试验(RCT)评估MedDiet对T2DM和MetS的影响。具有里程碑意义的地中海饮食预防(PREDIMED)营养干预试验结果表明,被分配到MedDiet组的参与者患T2DM的风险显著降低了30%,并且它还促进了MetS及其组成部分、高血糖和中心性肥胖的逆转。此外,5项RCT显示,与其他饮食模式相比,MedDiet对T2DM患者的血糖控制具有有益影响。最近一项对RCT的荟萃分析显示,与各种对照饮食相比,MedDiet对所有MetS组成部分都有有益影响。MedDiet的生物活性成分协同作用,影响各种代谢途径,从而降低心血管代谢疾病风险。构成以植物为基础的MedDiet的大量健康、营养丰富的食物预示了其生物活性以及有益影响导致MetS和T2DM的代谢途径以及其他慢性病的潜力。大量的流行病学和临床试验证据支持MedDiet在预防和管理T2DM和MetS方面的作用。